HEPATO CARCINOMA

Clinical trials for HEPATO CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new HEPATO CARCINOMA trials appear

Sign up with your email to follow new studies for HEPATO CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Diabetes drug januvia tested to boost immune attack on liver cancer

Disease control Completed

This pilot study tested the safety of giving sitagliptin (Januvia) for three weeks to 14 liver cancer patients before they had surgery to remove their tumors. The idea is that sitagliptin might help immune cells get into the tumor and fight it better. The main goal was to check f…

Matched conditions: HEPATO CARCINOMA

Phase: PHASE1 • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Disease control

Last updated Jun 26, 2026 12:57 UTC

HEPATO CARCINOMA

Get alerted when new HEPATO CARCINOMA trials appear

Diabetes drug januvia tested to boost immune attack on liver cancer